Cargando…

Killing of Serratia marcescens biofilms with chloramphenicol

Serratia marcescens is a Gram-negative bacterium with proven resistance to multiple antibiotics and causative of catheter-associated infections. Bacterial colonization of catheters mainly involves the formation of biofilm. The objectives of this study were to explore the susceptibility of S. marcesc...

Descripción completa

Detalles Bibliográficos
Autores principales: Ray, Christopher, Shenoy, Anukul T., Orihuela, Carlos J., González-Juarbe, Norberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370475/
https://www.ncbi.nlm.nih.gov/pubmed/28356113
http://dx.doi.org/10.1186/s12941-017-0192-2
_version_ 1782518246075793408
author Ray, Christopher
Shenoy, Anukul T.
Orihuela, Carlos J.
González-Juarbe, Norberto
author_facet Ray, Christopher
Shenoy, Anukul T.
Orihuela, Carlos J.
González-Juarbe, Norberto
author_sort Ray, Christopher
collection PubMed
description Serratia marcescens is a Gram-negative bacterium with proven resistance to multiple antibiotics and causative of catheter-associated infections. Bacterial colonization of catheters mainly involves the formation of biofilm. The objectives of this study were to explore the susceptibility of S. marcescens biofilms to high doses of common antibiotics and non-antimicrobial agents. Biofilms formed by a clinical isolate of S. marcescens were treated with ceftriaxone, kanamycin, gentamicin, and chloramphenicol at doses corresponding to 10, 100 and 1000 times their planktonic minimum inhibitory concentration. In addition, biofilms were also treated with chemical compounds such as polysorbate-80 and ursolic acid. S. marcescens demonstrated susceptibility to ceftriaxone, kanamycin, gentamicin, and chloramphenicol in its planktonic form, however, only chloramphenicol reduced both biofilm biomass and biofilm viability. Polysorbate-80 and ursolic acid had minimal to no effect on either planktonic and biofilm grown S. marcescens. Our results suggest that supratherapeutic doses of chloramphenicol can be used effectively against established S. marcescens biofilms. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12941-017-0192-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5370475
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53704752017-03-30 Killing of Serratia marcescens biofilms with chloramphenicol Ray, Christopher Shenoy, Anukul T. Orihuela, Carlos J. González-Juarbe, Norberto Ann Clin Microbiol Antimicrob Short Report Serratia marcescens is a Gram-negative bacterium with proven resistance to multiple antibiotics and causative of catheter-associated infections. Bacterial colonization of catheters mainly involves the formation of biofilm. The objectives of this study were to explore the susceptibility of S. marcescens biofilms to high doses of common antibiotics and non-antimicrobial agents. Biofilms formed by a clinical isolate of S. marcescens were treated with ceftriaxone, kanamycin, gentamicin, and chloramphenicol at doses corresponding to 10, 100 and 1000 times their planktonic minimum inhibitory concentration. In addition, biofilms were also treated with chemical compounds such as polysorbate-80 and ursolic acid. S. marcescens demonstrated susceptibility to ceftriaxone, kanamycin, gentamicin, and chloramphenicol in its planktonic form, however, only chloramphenicol reduced both biofilm biomass and biofilm viability. Polysorbate-80 and ursolic acid had minimal to no effect on either planktonic and biofilm grown S. marcescens. Our results suggest that supratherapeutic doses of chloramphenicol can be used effectively against established S. marcescens biofilms. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12941-017-0192-2) contains supplementary material, which is available to authorized users. BioMed Central 2017-03-29 /pmc/articles/PMC5370475/ /pubmed/28356113 http://dx.doi.org/10.1186/s12941-017-0192-2 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Short Report
Ray, Christopher
Shenoy, Anukul T.
Orihuela, Carlos J.
González-Juarbe, Norberto
Killing of Serratia marcescens biofilms with chloramphenicol
title Killing of Serratia marcescens biofilms with chloramphenicol
title_full Killing of Serratia marcescens biofilms with chloramphenicol
title_fullStr Killing of Serratia marcescens biofilms with chloramphenicol
title_full_unstemmed Killing of Serratia marcescens biofilms with chloramphenicol
title_short Killing of Serratia marcescens biofilms with chloramphenicol
title_sort killing of serratia marcescens biofilms with chloramphenicol
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370475/
https://www.ncbi.nlm.nih.gov/pubmed/28356113
http://dx.doi.org/10.1186/s12941-017-0192-2
work_keys_str_mv AT raychristopher killingofserratiamarcescensbiofilmswithchloramphenicol
AT shenoyanukult killingofserratiamarcescensbiofilmswithchloramphenicol
AT orihuelacarlosj killingofserratiamarcescensbiofilmswithchloramphenicol
AT gonzalezjuarbenorberto killingofserratiamarcescensbiofilmswithchloramphenicol